ARTICLE | Clinical News
Fidaxomicin regulatory update
August 23, 2010 7:00 AM UTC
The European Medicines Agency (EMA) accepted for review an MAA from Optimer for fidaxomicin to treat and prevent recurrence of Clostridium difficile infection. Optimer said it has retained JP Morgan t...